Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ibrutinib and infection risk

Ghez D et al. Blood. 2018 Feb 1. doi: 10.1182/blood-2017-11-818286.

Key clinical point: The tyrosine kinase inhibitor ibrutinib (Imbruvica) may be associated with early-onset invasive fungal infections.

Major finding: Of 33 identified cases, 27 were invasive aspergillosis.

Study details: Retrospective review of case reports from 16 French centers.

Disclosures: Dr. Ghez reported receiving a research grant from Janssen, and coauthor Loic Ysebaert, MD, PhD, reported consultancy fees with the company. All other authors declared no competing financial interests.

Source: Ghez D et al. Blood. 2018 Feb 1. doi: 10.1182/blood-2017-11-818286.

Read the full article.

Citation:

Ghez D et al. Blood. 2018 Feb 1. doi: 10.1182/blood-2017-11-818286.

This Week's Must Reads

Policy statement on access to opioid medications, Statement on Opioid Use in Patients with Hematologic Diseases and Disorders, American Society of Hematology

FDA approves Mircera for dialysis-related anemia in pediatric patients, FDA approved-drug notice, June 7, 2018; Mircena label (Drugs@FDA)

FDA approves pembrolizumab for relapsed/refractory PMBCL, FDA Press Announcement, June 15, 2018; Keytruda Prescribing Information (Drugs@FDA)

Poor adherence to DOAC therapy requires attention, Lakkireddy D et al. Heart Rhythm 2018, Abstract B-LBCT02-03.

Red cell tranfusion may increase risk of postsurgical VTE, Goel R et al. JAMA Surg. 2018 Jun 13. doi: 10.1001/jamasurg.2018.1565

Must Reads in Patient & Survivor Care

Skin side effects of therapies for hematologic cancers, Phillips et al. J Am Acad Dermatol. 2018;78:1102-9.

Monetary support affects select prescribing, Mitchell AP et al. JAMA Intern Med. 2018 Apr 9. doi: 0.1001/jamainternmed.2018.0776

Ibrutinib and infection risk, Ghez D et al. Blood. 2018 Feb 1. doi: 10.1182/blood-2017-11-818286.

Sequelae in Childhood Leukemia Survivors Assessed, Cancer; ePub 2017 Nov 3; Goldsby, Stratton, et al

Fatigue-Reducing Psychological Therapy, Cochrane; 2017 Jul 14; Poort, Peters, et al